MedPath

DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM

DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM

Approved
DIN Number

00865117

Drug Class

Human

Market Date

Dec 31, 1990

Company
HC

Vantive ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00865117
AIG Number0500162030
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormSolution
Route of AdministrationHaemodialysis (Intraperitoneal)
AHFS Classification40:34.00*
Health Canada Classification

ACTIVE INGREDIENTS (5)

CALCIUM CHLORIDEActive
Strength: 18.3 MG / 100 ML
Monograph: CALCIUM CHLORIDE
DEXTROSEActive
Strength: 4.25 G / 100 ML
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: 5.08 MG / 100 ML
Monograph: MAGNESIUM CHLORIDE
SODIUM CHLORIDEActive
Strength: 538 MG / 100 ML
Monograph: SODIUM CHLORIDE
SODIUM LACTATEActive
Strength: 448 MG / 100 ML
Monograph: SODIUM LACTATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.